Skip to main content
Signal8

Ikarian Capital, LLC

Ikarian Capital, LLC is an Investment Adviser institutional filer with the SEC under CIK 1778253, reporting 126 portfolio positions, with 21 historical 13F filings on file. Most recent reporting period: 2026-06-30.

A Form 13F reports a manager's US-listed stock and option positions only. It does not include real estate, private funds, bonds, cash or non-US holdings, so a 13F portfolio value is not the firm's total assets under management (AUM).

  • State of incorporation: DE
  • Filing type: 13F-HR
  • Latest reporting period: 2026-06-30
  • Last filed: 2026-08-14

Top 10 portfolio positions

The largest reported holdings in Ikarian Capital, LLC's most recent 13F filing, ranked by reported market value.

  1. ABIVAX SA (ABVX)
  2. KODIAK SCIENCES INC (KOD)
  3. ALUMIS INC (ALMS)
  4. PRAXIS PRECISION MEDICINES I (PRAX)
  5. VAXCYTE INC (PCVX)
  6. ANI PHARMACEUTICALS INC (ANIP)
  7. CELLDEX THERAPEUTICS INC NEW (CLDX)
  8. ARCUS BIOSCIENCES INC (RCUS)
  9. RELMADA THERAPEUTICS INC (RLMD)
  10. CAPRICOR THERAPEUTICS INC (CAPR)
/